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The myelin-forming oligodendrocytes of the mouse embryonic spinal cord express the three group E Sox proteins Sox8, Sox9, and
Sox10. They require Sox9 for their specification from neuroepithelial cells of the ventricular zone and Sox10 for their terminal differentiation
and myelination. Here, we show that during oligodendrocyte development, Sox8 is expressed after Sox9, but before Sox10. Loss of Sox8 did
not impair oligodendrocyte specification by itself, but enhanced the Sox9-dependent defect. Oligodendrocyte progenitors were still generated
in the Sox9-deficient spinal cord, albeit at 20-fold lower rates than in the wildtype. Combined loss of Sox8 and Sox9, in contrast, led to a near
complete loss of oligodendrocytes. Other cell types such as ventricular zone cells and radial glia remained unaffected in their numbers as well
as their rates of proliferation and apoptosis. Oligodendrocyte development thus relies on the differential contribution of all three group E Sox
proteins at various phases.
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Oligodendrocytes are the myelin-forming glial cells of
the central nervous system. In the spinal cord, they are
primarily generated from neuroepithelial cells in a defined
ventral region of the ventricular zone (Rowitch, 2004).
Neuroepithelial cells in this pMN domain give also rise to
motoneurons. However, generation of motoneurons and
oligodendrocytes is temporally separated with motoneuron
production preceding oligodendrogenesis. Several transcrip-
tion factors with importance for generation, development,
and differentiation of oligodendrocytes have been charac-
terized over the last years, including the bHLH proteins
Olig2 and Olig1 and homeodomain proteins of the Nkx
family (Rowitch et al., 2002; Wegner, 2001).
Sox proteins represent another group of transcription
factors that figure prominently in oligodendrogenesis. With0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.03.010
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groove of DNA in a sequence-specific manner, thereby
widening the minor groove and introducing a strong bend
into the DNA (Bowles et al., 2000; Wegner, 1999). Of the
twenty mammalian Sox proteins, Sox10 and its relatives
Sox8 and Sox9 (also referred to as group E Sox proteins) are
expressed in spinal cord oligodendrocytes in a complex and
overlapping manner. We have previously shown that Sox9 is
already present in neuroepithelial cells of the pMN domain,
whereas the onset of Sox10 expression coincides with
specification to the oligodendrocyte lineage (Stolt et al.,
2003). After specification, both proteins are co-expressed in
developing oligodendrocytes until terminal differentiation
when Sox9 expression is extinguished. Sox10, in contrast,
continues to be expressed and is involved in activating
myelin gene expression as part of the terminal differ-
entiation program in oligodendrocytes (Stolt et al., 2002).
Defects in oligodendrocyte development were observed
in the absence of Sox9 and Sox10 with Sox9-specific
defects preceding those occurring in the absence of Sox10.
In the Sox9-deficient spinal cord, oligodendrocyte specifi-281 (2005) 309 – 317
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al., 2003), whereas oligodendrocytes in the Sox10-deficient
spinal cord failed to undergo terminal differentiation at the
end of embryogenesis (Stolt et al., 2002). However, neither
the early specification defect in the Sox9-deficient spinal
cord nor the terminal differentiation defect in Sox10-
deficient spinal cord was absolute. In case of the terminal
differentiation defect, residual myelin gene expression was
attributed to Sox8 occurrence in oligodendrocytes (Stolt et
al., 2004). Expression levels at this time were considerably
lower for Sox8 than for Sox10. This may explain why Sox8
can be deleted from oligodendrocytes without any obvious
developmental consequences and why it compensates loss
of Sox10 so inefficiently (Sock et al., 2001; Stolt et al.,
2004).
Here, we analyze Sox8 expression during early phases of
oligodendrocyte development. We show that Sox8 is already
expressed around the time of oligodendrocyte specification
in neuroepithelial cells of the ventricular zone and that its
presence is responsible for remaining oligodendrocyte
progenitors in the Sox9-deficient spinal cord. Accordingly,
oligodendrogenesis is virtually absent in spinal cords
deficient for Sox8 and Sox9.Materials and methods
Animal husbandry, genotyping, BrdU labeling, tissue
preparation, and in situ hybridization
Mice with Sox9loxP alleles (Akiyama et al., 2002) and
additional Sox8lacZ (Sock et al., 2001) alleles were kept as
doublehomozygous females, or asdoubleheterozygousmales
in the presence of a nestin Cre transgene (Tronche et al.,
1999) and crossed to generate CNS-specific Sox8lacZ/lacZ,
Sox9D/D embryos. Genotyping was performed by PCR (Sock
et al., 2001; Stolt et al., 2003).
Embryos (from 10.5 dpc to 16.5 dpc) were obtained from
staged pregnancies. After fixation in 4% paraformaldehyde,
10-Am sections of genotyped, age-matched mouse embryos
were generated on a Leica cryotome, and used for
immunohistochemistry. Alternatively, 20-Am sections were
used for in situ hybridization with DIG-labeled probes
specific for Olig2, PDGF receptor a, and Myelin Basic
Protein (MBP) as described (Stolt et al., 2002). For BrdU
labeling, pregnant mice were injected intraperitoneally with
100 Ag BrdU (Sigma) per gram body weight 2 h before
embryo preparation (Stolt et al., 2003).
Antibody production, immunohistochemistry, and TUNEL
assays
Antibodies against Sox8 were generated in guinea pig
against a purified bacterially expressed protein consisting of
amino acids 2–60 of mouse Sox8 fused to glutathione-S-
transferase. For immunohistochemistry, 10-Am cryotomesections from the forelimb level of genotyped, age-matched
mouse embryos were used with the following primary
antibodies: anti-PCNA mouse monoclonal (1:100 dilution,
Roche Biochemicals), anti-Hb9 mouse monoclonal (1:50
dilution, Developmental Studies Hybridoma Bank), anti-
Nkx2.2 mouse monoclonal (1:50 dilution, Developmental
Studies Hybridoma Bank), anti-SoxB1 rabbit antiserum
(1:500 dilution, Tanaka et al., 2004), anti-B-FABP rabbit
antiserum (1:10,000 dilution, gift of C. Birchmeier and T.
Mu¨ller, MDC, Berlin), anti-Olig2 rabbit antiserum (1:2000
dilution, gift of H. Takebayashi, Kyoto University), affinity-
purified anti-Sox9 rabbit antiserum (1:2000 dilution, Stolt et
al., 2003), anti-Sox10 guinea pig antiserum (1:2000
dilution, Maka et al., 2005), anti-Sox8 guinea-pig antiserum
(1:2000 dilution), or anti-Nkx6.1 guinea-pig antiserum
(1:1000, gift of M. Sander, UCI, Irvine). Secondary
antibodies conjugated to Cy2 and Cy3 immunofluorescent
dyes (Dianova) were used for detection. Incorporated BrdU
was detected on tissue sections using an Alexa-488 coupled
mouse monoclonal antibody directed against BrdU (Molec-
ular Probes) at a 1:20 dilution. TUNEL assays were
performed according to the manufacturer’s protocol (Chem-
icon). Samples were analyzed and documented using a
Leica inverted microscope (DMIRB) equipped with a
cooled MicroMax CCD camera (Princeton Instruments,
Trenton, NJ).Results
Sox8 appears in the ventral spinal cord after Sox9, but
before Sox10
Using a lacZ marker inserted into the Sox8 genomic
locus, we have previously shown that cells of the
oligodendrocyte lineage in the spinal cord of Sox8+/lacZ or
Sox8lacZ/lacZ mice express Sox8 (Sock et al., 2001; Stolt et
al., 2004). A newly developed antibody against Sox8 now
allowed us to directly study Sox8 occurrence in the wildtype
spinal cord in comparison to its close relatives Sox9 and
Sox10. At 10.5 dpc, Sox8 was not yet expressed at
sufficiently high levels to be detected by the antibody in
the forelimb region of the spinal cord (Fig. 1b). Similarly,
Sox10 was absent from the spinal cord and occurred only in
the developing peripheral nervous system (Fig. 1c). At the
same time, Sox9 was already strongly expressed in neuro-
epithelial cells throughout the ventricular zone of the spinal
cord (Fig. 1a). Whereas there was still no Sox10 expression
at 11.0 dpc (Fig. 1f ), weak immunoreactivity against Sox8
became visible at this stage in the ventral part of the
ventricular zone (Fig. 1e). By 11.5 dpc, intensity of this
signal had increased so that Sox8 protein was now easily
detected in nuclei of ventricular zone cells (Fig. 1h). Sox8-
positive cells were restricted to the ventral region of the
spinal cord, including the pMN domain from which the first
oligodendrocyte progenitors emigrated at this time as
Fig. 1. Comparative expression of group E Sox proteins in the embryonic
spinal cord. Immunohistochemistry with antibodies specific for Sox9
(a,d,g,j), Sox8 (b,e,h,k), and Sox10 (c,f,i,l) were performed on transverse
sections from the forelimb region of wildtype embryos at 10.5 dpc (a–c),
11.0 dpc (d– f), 11.5 dpc (g– i), and 12.5 dpc (j – l).
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12.5 dpc, Sox8 was still strongly expressed in the same
region of the ventral spinal cord (Fig. 1k). Additionally,
weak Sox8 staining was detected in ventricular zone cells of
the dorsal spinal cord. At the same time, the number of
Sox10-positive oligodendrocyte progenitors had increased
significantly (Fig. 1l). Sox9 expression persisted throughout
the ventricular zone (Figs. 1g,j).
To determine which ventricular zone cells exactly
express Sox8 at 11.5 dpc, we performed co-immunohisto-
chemistry (Fig. 2). Co-expression of Sox8 with Nkx2.2Fig. 2. Expression of Sox8 protein in the ventral ventricular zone. Co-
immunohistochemistry on the ventral spinal cord of 11.5 dpc-old wildtype
embryos with antibodies against Sox8 (red) and the domain markers (all in
green) Nkx2.2 (a), Olig2 (b), and Nkx6.1 (c). Identified domains of the
ventral ventricular zone are listed on the right.(Fig. 2a) and Olig2 (Fig. 2b), which at this time are specific
markers for the p3 and the pMN domain, respectively
(Jessell, 2000), pointed to strong Sox8 expression in the two
ventralmost domains of the ventricular zone. Lower
amounts of Sox8 were additionally present dorsally adjacent
to the pMN domain (Fig. 2). Expression of Sox8 extended
farther from the floorplate than that of Nkx6.1 (Fig. 2c)
which ends in the p2 domain (Jessell, 2000). Thus, the
region of Sox8 expression in the ventral spinal cord reaches
at least into the p1 domain.
Sox8 was expressed in ventricular zone cells together
with Sox9 (Figs. 3a–c) as well as in oligodendrocyte
progenitors in combination with both Sox9 (Figs. 3a–c) and
Sox10 (Figs. 3d–f). We conclude that, within the pMN
domain, Sox8 appears in cells that already contain Sox9.
These cells give rise to oligodendrocyte progenitors that
additionally turn on Sox10 expression.
Loss of Sox8 does not alter ventricular zone and radial glia
development even in the absence of Sox9
Previous studies have already revealed that spinal cord
development in the absence of Sox8 proceeds normally
(Sock et al., 2001). Similarly, no developmental defects
were detected in the spinal cord of Sox8-deficient mice that
additionally lacked one Sox10 allele until late in embryo-
genesis (Stolt et al., 2004). Therefore, we asked whether
spinal cord development would be affected in the combined
absence of Sox8 and Sox9. For these studies, Sox9 had to be
deleted in a tissue-specific manner using a loxP-containing
Sox9 allele (Akiyama et al., 2002; Stolt et al., 2003) in
combination with a CRE transgene under the control of
regulatory sequences from the nestin gene (Tronche et al.,
1999). Using this strategy, Sox9 was largely ablated from
the spinal cord in the forelimb area by 12.5 dpc. Only few
Sox9 expressing cells remained as previously shown (Stolt
et al., 2003). When development of ventricular zone cells
and radial glia was analyzed in these Sox8lacZ/lacZ, Sox9D/DFig. 3. Co-expression of group E Sox proteins in the embryonic spinal cord.
Immunohistochemistry on the pMN domain of 12.5 dpc-old wildtype
embryos with antibodies against Sox8 (green in a,c,d,f), Sox9 (red in b,c),
or Sox10 (red in e,f) is presented as single (a,b,d,e) or merged (c,f) pictures.
Several oligodendrocyte precursors are marked with arrowheads.
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proteins, nestin, or brain fatty acid binding protein (B-
FABP), no differences were detected relative to the wildtype
both regarding distribution (compare Figs. 4a,c,e to 4b,d,f)
and quantity (Fig. 4k and data not shown). Supporting the
notion that ventricular zone cells were present in normal
numbers and had retained their identity, Olig2-positive
neuroepithelial cells were present at the expected dorsoven-
tral position (Figs. 4i,j) and were found in wildtype numbers
in Sox8lacZ/lacZ,Sox9D/D spinal cords (VZ in Figs. 4m).
Neither BrdU labeling experiments on Sox8lacZ/lacZ,Sox9D/D
spinal cords nor immunohistochemistry for proliferating cell
nuclear antigen (PCNA) revealed significant deviationsFig. 4. Ventricular zone, radial glia, and motoneuron development in embryonic s
with antibodies directed against SoxB1 proteins (SoxB1 in a,b), B-FABP (c,d, as w
Olig2 (i,j) were performed on transverse sections from the forelimb region of wildt
m) Quantification of B-FABP-positive cells (k), Hb9-positive cells (l), and Oli
Sox8lacZ/lacZ,Sox9D/D embryos (filled bars) at 12.5 dpc. At least 15 separate 10-Am
for each genotype. The number of Hb9-positive cells in the medial region (region
cells including those in the ventral horn (region 2, inset) (l), as was the number of
Data are presented as mean T SEM. Differences to the wildtype (set to 100%) w
Student’s t test ( P  0.001) in case of medial Hb9-positive cells (300% T 89%),
ventricular zone (7% T 7%).from the wildtype situation (Figs. 5a,b,c,d,g) arguing that
overall proliferation rates at this early stage are normal. We
equally failed to detect differences in apoptosis rates using
TUNEL assays (Figs. 5e,f,h).
Motoneuron numbers, in contrast, were higher in the
Sox8lacZ/lacZ,Sox9D/D spinal cords at 12.5 dpc than in the
wildtype (Figs. 4g,h). The overall number of Hb9-positive
cells was increased by 44% (1 + 2 in Fig. 4l). The
subpopulation of Hb9-positive cells, that were still at a
medial position close to the ventricular zone, was threefold
larger (1 in Fig. 4l), presumably indicating that significant
numbers of motoneurons were still born in the Sox8lacZ/lacZ,
Sox9D/D spinal cords at 12.5 dpc. The increase in moto-pinal cord deficient for both Sox8 and Sox9. (a– j) Immunohistochemistry
ell as higher magnification of the ventral spinal cord in e,f), Hb9 (g,h), and
ype (a,c,e,g,i) and Sox8lacZ/lacZ,Sox9D/D embryos (b,d,f,h,j) at 12.5 dpc. (k–
g2-positive cells (m) in ventral spinal cords of wildtype (open bars) and
sections from the forelimb region of 2 independent embryos were counted
1, inset) was separately determined from the total number of Hb9-positive
Olig2-positive cells within (VZ) and outside (MZ) the ventricular zone (m).
ere statistically significant for the mutant genotype as determined by the
total Hb9-positive cells (144% T 28%), and Olig2-positive cells outside the
Fig. 5. Proliferation and apoptosis in embryonic spinal cord deficient for both Sox8 and Sox9. (a– f) Immunohistochemistry with antibodies specific for the S
phase marker PCNA (a,b) or BrdU (c,d) was performed on transverse sections from the forelimb region of 12.5 dpc-old embryos previously labeled for 2 h with
BrdU. Adjacent sections were used for TUNEL assays (e,f). (a,c,e) Wildtype embryos; (b,d,f) Sox8lacZ/lacZ,Sox9D/D embryos. (g,h) Quantification of BrdU-
labeled cells in the ventral spinal cord (g), and TUNEL-positive cells in the total spinal cord (h) of wildtype (open bars) and Sox8lacZ/lacZ,Sox9D/D embryos
(filled bars) at 12.5 dpc. At least 15 separate 10-Am sections from the forelimb region of 2 independent embryos were counted for each genotype. Data are
presented as mean T SEM. No statistically significant differences to the wildtype were detected for the mutant genotype as determined by the Student’s t test.
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spinal cords (Stolt et al., 2003). No surplus motoneurons
were generated at later phases of development, indicating
that even in the absence of Sox8 and Sox9, neuroepithelial
cells in the pMN domain at some point lose their
competence to develop into motoneurons. At these later
stages, pMN domain cells in the Sox8lacZ/lacZ,Sox9D/D spinal
cords rather appear to persist as radial glia.
Combined loss of Sox8 and Sox9 prevents
oligodendrogenesis
In Sox9D/D spinal cords, the transient increase in
motoneuron numbers was accompanied by a simultaneous
decrease in oligodendrocyte progenitors (Stolt et al., 2003).
However, this specification defect was not complete.
Oligodendrocyte progenitors were born at a twenty-fold
lower number than in the wildtype, but were able to
replenish the oligodendrocyte progenitor pool as embryonic
development proceeded so that oligodendrocyte numbers
had recovered to 70% by 16.5 dpc (Stolt et al., 2003).
In wildtype embryos, Olig2-positive cells are found at
12.5 dpc both in the ventricular zone and in the mantle zone
with the latter population corresponding to oligodendrocyte
progenitors (Figs. 4i,m). In Sox8lacZ/lacZ,Sox9D/D spinal
cords, Olig2-positive cells were selectively lost from themantle zone (Figs. 4j,m). Labeling of oligodendrocyte
progenitors and neuroepithelial cells in the pMN domain
by Olig2 makes it difficult to distinguish between both
populations at early times of development with this marker.
Sox10, in contrast, is selectively expressed in the oligoden-
drocyte lineage (Figs. 3e and 6a). Immunolabeling failed to
detect Sox10-positive cells in the Sox8lacZ/lacZ,Sox9D/D
spinal cord at 12.5 dpc (Fig. 6e). Even at 14.5 and 16.5
dpc, Sox10-positive oligodendrocyte progenitors were not
detected in the Sox8lacZ/lacZ,Sox9D/D spinal cord (Figs. 6f,g).
In contrast, oligodendrocyte progenitors had proliferated
and spread throughout the parenchyma of the wildtype
spinal cord (Figs. 6b,c). Our failure to detect Sox10 even at
16.5 dpc, when oligodendrocyte numbers in the Sox9D/D
spinal cord had expanded to 70% of wildtype levels,
impressively confirmed the increased severity of the
oligodendrocyte specification defect in the Sox8/Sox9-
double deficient mouse.
To exclude the possibility that significant numbers of
oligodendrocyte progenitors were still present in the absence
of Sox10 expression, we employed additional markers of
the oligodendrocyte lineage. Immunohistochemistry
revealed only few, weakly Olig2-positive cells in some
Sox8lacZ/lacZ,Sox9D/D spinal cords at 14.5 dpc and 16.5 dpc
(Figs. 6d,h,i). No Olig2 signal was detected by in situ
hybridization (Figs. 7a,b). PDGF receptor a-positive cells
Fig. 6. Oligodendrocyte development in the embryonic Sox8/Sox9-deficient spinal cord. (a–h) Immunohistochemistry with antibodies specific for the
oligodendrocyte marker Sox10 (a,b,c,e,f,g) and Olig2 (d,h) was performed on transverse sections of wildtype spinal cords (a–d) and Sox8lacZ/lacZ,Sox9D/D
spinal cords (e–h) from the forelimb region. (a,e) 12.5 dpc; (b,f) 14.5 dpc; (c,d,g,h) 16.5 dpc. (i) Quantification of Olig2-positive cells in wildtype (open bars)
and Sox8lacZ/lacZ,Sox9D/D (filled bars) spinal cords at 14.5 dpc and 16.5 dpc. At least 15 separate 10-Am sections from the forelimb region of 2 independent
embryos were counted for each genotype. Data are presented as mean T SEM. Differences to the wildtype (set to 100%) were statistically significant for the
mutant genotype as determined by the Student’s t test ( P  0.001) both at 14.5 dpc (2% T 2%) and at 16.5 dpc (5% T 3%).
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earlier times in the Sox8lacZ/lacZ,Sox9D/D spinal cord (com-
pare Figs. 7d,f to 7c,e and data not shown). Additionally,
less than one proliferating and therefore oligodendroglial
Nkx2.2-expressing cell (Zhou et al., 2001) was on average
observed per section in the mantle zone of Sox8lacZ/lacZ,Fig. 7. Oligodendrocyte marker gene expression in the embryonic Sox8/
Sox9-deficient spinal cord. In situ hybridization with antisense probes
specific for the oligodendrocyte markers Olig2 (a,b), PDGF receptor a
(PDGF-Ra in c,d), and MBP (e,f) was performed on transverse sections
from the forelimb region of wildtype (a,c,e) and Sox8lacZ/lacZ,Sox9D/D
(b,d,f) embryos at 16.5 dpc.Sox9D/D spinal cords at 16.5 dpc. The strong reduction of all
analyzed markers of the oligodendrocyte lineage argues that
there are indeed very few remaining oligodendrocyte
progenitors in the developing spinal cord of Sox8/Sox9-
double deficient mice.Discussion
All three group E Sox proteins are expressed in the
oligodendrocyte lineage
Of the three group E Sox proteins, Sox9 is strongly
expressed in chondrocytes, whereas neural crest cells
express high levels of Sox10 (for a review, see Wegner,
1999). Dramatic phenotypes are observed in many tissues
with high levels of Sox protein expression after loss of
the respective Sox protein, leading to the skeletal mal-
formation syndrome Campomelic Dysplasia following
Sox9 inactivation (Foster et al., 1994; Wagner et al.,
1994), and Waardenburg–Hirschsprung syndrome after
Sox10 loss (Pingault et al., 1998).
Oligodendrocytes, the myelin-forming glia of the central
nervous system, express significant amounts of all three
group E Sox proteins. Whereas Sox9 and Sox10 have been
detected with specific antibodies, Sox8 expression has so far
only been analyzed via a lacZ reporter that was integrated
into the Sox8 locus during gene deletion and so far appeared
to faithfully recapitulate Sox8 expression (Sock et al., 2001;
Stolt et al., 2004). Here, we directly detected Sox8 protein in
cells of the oligodendrocyte lineage. This is important as
minor discrepancies between expression of Sox8 and the
lacZ reporter still cannot be excluded and actually seem to
exist. Expression of the lacZ reporter in the ventricular zone
of the spinal cord was, for instance, only detected in an area
C.C. Stolt et al. / Developmental Biology 281 (2005) 309–317 315surrounding the pMN domain and appeared thus more
restricted than Sox8 expression (Stolt et al., 2003).
Similarly, lacZ expression in the spinal cord outside the
ventricular zone was mostly restricted to cells of the
oligodendrocyte lineage, whereas Sox8 is additionally found
in a significant fraction of radial glia.
In the spinal cord, the three group E Sox proteins are
turned on successively with Sox9 preceding Sox8 which in
turn appears before Sox10. Due to the different onset of
expression, Sox9 and Sox8 are already expressed in
neuroepithelial cells, including those of the pMN domain
whereas the onset of Sox10 expression is concomitant with
specification to oligodendrocyte progenitors.
In addition to this sequential induction of Sox gene
expression during early oligodendrocyte development, there
is a selective down-regulation at later phases. Terminally
differentiating oligodendrocytes turn off Sox9, but continue
to express Sox8 and Sox10 (Stolt et al., 2003, 2004). There
is also evidence for different levels of Sox gene expression
in the oligodendrocyte lineage. Thus, during late oligoden-
drocyte development, Sox10 appears to be expressed at
higher levels than Sox8 (Stolt et al., 2004). Taking these
qualitative and quantitative differences into account, it is
possible to explain oligodendrocyte development in genet-
ically altered mice with functional loss of group E Sox
genes.
Sox8 has accessory roles both in early and late
oligodendrocyte development
In agreement with its high expression levels in the pMN
domain at the time of oligodendrocyte specification, loss of
Sox9 leads to specification defects of the oligodendrocyte
lineage (Stolt et al., 2003). This defect, however, is not
complete and a few residual oligodendrocyte progenitors
were detected that later expanded and replenished the
oligodendrocyte progenitor pool. Here, we show that
additional removal of Sox8 strongly enhances the severity
of this oligodendrocyte specification defect, arguing that
Sox9 and Sox8 cooperate in their ability to specify
oligodendrocytes. Taking into account that loss of Sox8
on its own has no influence on oligodendrocyte specifica-
tion (Sock et al., 2001; Stolt et al., 2004), Sox8 clearly has a
smaller impact than Sox9.
It is conceivable that the few oligodendrocyte progenitors
that originally become specified in the Sox9-deficient spinal
cord owe their existence to the mode of Cre-dependent Sox9
ablation. Mosaic and variable Cre activity as well as the
latency between deletion of gene and protein allow Sox9
persistence in a small number of neuroepithelial cells at the
right time and place for oligodendrogenesis. Residual Sox9
might in turn be sufficient to drive oligodendrocyte
specification on the background of endogenous Sox8 in
these cells. Alternatively, neuroepithelial cells within the
pMN domain may differ in their amount of endogenous
Sox8 so that a subpopulation with high amounts of Sox8can indeed cope with the loss of Sox9 and still undergo
specification to oligodendrocytes.
This accessory role in early specification is paralleled by
a similar role of Sox8 in late oligodendrocyte development.
During terminal differentiation, Sox8 cooperates with
Sox10 in the activation of the myelination program (Stolt
et al., 2004). Compared to Sox10, Sox8 is expressed at
lower levels and again appears to play a relatively minor
role.
In the absence of Sox9 and therefore also in the absence
of Sox9 and Sox8, surplus motoneurons are generated for a
prolonged period from the pMN domain. We have
previously argued that the most plausible explanation for
these motoneurons is that they are produced instead of
oligodendrocyte progenitors because their generation coin-
cides with the normal time of oligodendrocyte specification
and correlates with a reciprocal decrease in oligodendrocyte
progenitors (Stolt et al., 2003). The increase was only
transient because of the apoptotic adjustment of motoneuron
numbers to target tissue innervation (Yamamoto and
Henderson, 1999) and the failure to produce further
motoneurons at later phases of development. Even in the
absence of Sox9 and Sox8, neuroepithelial cells in the pMN
domain at some point lose their competence to develop into
motoneurons, possibly through loss of neurogenic tran-
scription factors such as Neurogenin2 (Mizuguchi et al.,
2001).
Implications for group E Sox protein function
The joint regulation of developmental processes by
multiple group E Sox proteins might be fairly common.
Thus, functional cooperation of Sox9 and Sox8 has been
observed during development of the male gonad (Chaboiss-
ier et al., 2004), and might also be at work during muscle
development (Schmidt et al., 2003).
Of the three group E Sox proteins, Sox8 appears to have
the most widespread expression during embryogenesis
(Pfeifer et al., 2000; Schepers et al., 2000; Sock et al.,
2001). At the same time, it also appears to be the least
important as it is the only group E Sox protein that can be
deleted in mammals without affecting viability (Bi et al.,
1999; Britsch et al., 2001; Sock et al., 2001). Many Sox8-
expressing tissues tolerate deletion of the gene, whereas
their development is strongly impaired when the co-
expressed Sox9 or Sox10 is deleted. So far, osteoblasts are
the only cell type shown to depend on Sox8 for proper
development (Schmidt et al., 2005).
Co-expression of group E Sox proteins likely is a
consequence of their evolutionary history. Invertebrates
possess a single group E Sox protein, whereas vertebrates
have three group E Sox proteins or – in case of teleosts –
three duplicated sets (Bowles et al., 2000; Koopman et al.,
2004). Therefore, group E Sox proteins must have arisen
early in the vertebrate lineage from a single common
ancestor. Their overlapping expression pattern furthermore
C.C. Stolt et al. / Developmental Biology 281 (2005) 309–317316indicates that each of the three group E Sox proteins has
inherited most of its expression domains from this
common ancestor. Whereas Sox9 and Sox10 have lost
some of the original expression domains and retained (or
gained) strong expression levels in the remaining ones,
Sox8 may have best preserved the ancestoral expression
pattern. The main function of Sox8 may now be in
osteoblasts and other cell types that rely on Sox8 for their
development. Low expression levels in several other
tissues, including oligodendrocytes, may rather be an
evolutionary relic than a physiologically relevant back-up
mechanism, because Sox8 cannot effectively compensate
loss of Sox9 or Sox10.
In such a model, function of all three Sox proteins is
considered equivalent at first approximation so that the
differential contribution of each family member to a
phenotype is primarily a function of its amount in the
respective tissue or cell type. In support of such a model,
comparative biochemical studies have so far failed to reveal
significant functional differences between different group E
Sox proteins (Schepers et al., 2003; Stolt et al., 2004).
Ectopic expression studies in the chick embryo furthermore
indicate that all three group E Sox proteins influence early
neural crest development identically (Cheung and Briscoe,
2003).
Nevertheless, functional differences between the three
group E Sox proteins may so far have gone unnoticed.
The existence of unique functions for Sox8 would
explain why at least low levels of Sox8 are maintained
in tissues or cell lineages that mostly rely for their
development on the other group E Sox proteins.
Furthermore, these functions would have to be subtle,
as their loss is not phenotypically evident under standard
housing conditions in Sox8-deficient mice. Replacing one
group E Sox gene by another in the mouse will be
helpful in solving this issue.Note added in revision
While this manuscript was under revision, oligodendro-
cytes were shown to be generated in the spinal cord not only
from the pMN domain, but in addition from a dorsal domain
at a later time (Cai et al., 2005; Vallstedt et al., 2005). On the
basis of these reports and our findings, we have to conclude
that combined loss of Sox8 and Sox9 also interferes with
oligodendrogenesis from this second domain.Acknowledgments
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